MGC Pharmaceuticals Limited PDMR Notification
March 28 2024 - 4:12AM
RNS Regulatory News
RNS Number : 6895I
MGC Pharmaceuticals Limited
28 March 2024
MGC
Pharmaceuticals Ltd.
PDMR
Notification
28 March
2024
ASX, LSE:
MXC
MGC
Pharmaceuticals Ltd ('MGC Pharma' or
'the Company')
wishes to advise that the following Persons
Discharging Managerial Responsibilities
(PDMR) were issued a
combined 240,000 unlisted options as approved at a meeting of
shareholders on 18 March 2024. This notification is made in
accordance the UK Market Abuse Regulations.
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
(a)
|
Name
|
Daniel Robinson
|
|
2
|
Reason for the notification
|
|
(a)
|
Position
|
Non-Executive Director
|
|
(b)
|
Initial
notification/amendment
|
Initial
|
|
(c)
|
If amendment: reason
|
n/a
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Full name of entity
|
MGC Pharmaceuticals
Limited
|
|
|
Legal Entity Identifier
Code
|
213800HRE3FQJ6RK4H10
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; (iv) each place where transactions have been
conducted
|
|
(a)
|
Description of the financial
instrument, type of instrument
|
Unlisted options exercisable at
A$0.42 on or before 28 March 2027.
|
|
(b)
|
Identification Code (ISIN)
|
AU000000MXC6
|
|
(c)
|
Nature of transaction
|
Grant of Options over Ordinary
Shares
|
|
(d)
|
Currency
|
Price
|
Volume
|
Total
|
|
|
AUD
|
0.00
|
120,000
|
N/A
|
|
|
Aggregated
information
|
|
|
AUD
|
0.00
|
120,000
|
N/A
|
|
(e)
|
Date of transaction
|
28 March 2024
|
|
(f)
|
Place of transaction
|
Outside a trading venue
|
|
|
|
|
|
| |
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
(a)
|
Name
|
Layton Mills
|
|
2
|
Reason for the notification
|
|
(a)
|
Position
|
Non-Executive Director
|
|
(b)
|
Initial
notification/amendment
|
Initial
|
|
(c)
|
If amendment: reason
|
n/a
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Full name of entity
|
MGC Pharmaceuticals
Limited
|
|
|
Legal Entity Identifier
Code
|
213800HRE3FQJ6RK4H10
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; (iv) each place where transactions have been
conducted
|
|
(a)
|
Description of the financial
instrument, type of instrument
|
Unlisted options exercisable at
A$0.42 on or before 28 March 2027.
|
|
(b)
|
Identification Code (ISIN)
|
AU000000MXC6
|
|
(c)
|
Nature of transaction
|
Grant of Options over Ordinary
Shares
|
|
(d)
|
Currency
|
Price
|
Volume
|
Total
|
|
|
AUD
|
0.00
|
120,000
|
N/A
|
|
|
Aggregated
information
|
|
|
AUD
|
0.00
|
120,000
|
N/A
|
|
(e)
|
Date of transaction
|
28 March 2024
|
|
(f)
|
Place of transaction
|
Outside a trading venue
|
|
|
|
|
|
| |
-Ends-
Authorised for release by the Company Secretary, for further
information please contact:
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHGCGDXLGDDGSI
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Apr 2023 to Apr 2024
